Insider Trading & Ownership of PharmaCyte Biotech, Inc.

Location
Las Vegas, NV
Signature
/s/ Joshua N. Silverman, President and CEO
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow PharmaCyte Biotech, Inc. and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • PharmaCyte Biotech, Inc. has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: FEMASYS INC ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of PharmaCyte Biotech, Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
FEMY FEMASYS INC 10%+ Owner 17 Mar 2026
QCLS Q/C TECHNOLOGIES, INC. 10%+ Owner 04 Sep 2025

Insider Transactions Reported by PharmaCyte Biotech, Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored